Navigation Links
CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
Date:4/26/2012

in the recall or seizure of previously cleared or approved tissues and products, our HemoStase sales ceased in late March 2011, and we will not be able to participate in the hemostats market in the U.S. or other markets where we lack regulatory approval unless we can obtain FDA or other regulatory approval for PerClot, we may not be successful in obtaining necessary clinical results and regulatory approvals for services and products in development, and our new services and products may not achieve market acceptance, uncertainties related to patents and protection of proprietary technology may adversely impact the value of our intellectual property, intense competition may impact our ability to operate profitably, if we are not successful in expanding our business activities in international markets, we may be unable to increase our revenues, we are dependent on the availability of sufficient quantities of tissue from human donors, key growth strategies may not generate the anticipated benefits, investments in new technologies and acquisitions of products or distribution rights may not be successful, regulatory action outside of the U.S. has affected our business in the past and may affect our business in the future, consolidation in the healthcare industry could continue to result in demands for price concessions, limits on the use of our tissues and products, and limitations on our ability to sell to certain of our significant market segments, extensive government regulations may adversely impact our ability to develop and market services and products, the success of many of our tissues and products depends upon strong relationships with physicians, our existing insurance policies may not be sufficient to cover our actual claims liability, we may be unable to obtain adequate insurance at a reasonable cost, if at all, we are not insured against all potential losses, and natural disasters or other catastrophes could adversely impact our business, financial condition
'/>"/>
SOURCE CryoLife, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial Results
2. CryoLife Enhances Management Team with Promotions
3. CryoLife to Present at 6th Annual Canaccord Genuity Cardiovascular, Aesthetics & Metabolic Disorders Conference
4. CryoLife to Present at 23rd Annual Piper Jaffray Health Care Conference
5. CryoLife Reports Financial Results for the Third Quarter and First Nine Months of 2011
6. CryoLife Initiates Enrollment in U.S. Clinical Trial for BioFoam®
7. CryoLife Announces Release Date and Teleconference Call Details for 2011 Third Quarter Financial Results
8. CryoLife Provides Update on ValveXchange®, Inc. Investment
9. CryoLife Reports Record Revenues for the Second Quarter and First Six Months of 2011
10. CryoLife Announces Release Date and Teleconference Call Details for 2011 Second Quarter Financial Results
11. CryoLife Makes Equity Investment in ValveXchange® Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... Feb. 26, 2015 Surna Inc. (OTCQB: ... in commercial indoor cannabis cultivation technology, announced today ... start-up to fast-paced manufacturing and engineering company. ... current Director and CEO, will be stepping down ... of what the team has accomplished thus far ...
(Date:2/26/2015)... N.Y. , Feb. 26, 2015 ... year at the Clearwater Beach Hilton to provide ... technology to plant reliability professionals from around the ... a stellar collection of leaders in the field ... the demand for excellence continues with this year,s ...
(Date:2/26/2015)... -- Medtronic, Inc. (U.S.), St. Jude Medical, Inc. ... the Saudi Arabia , South ... to lead the market during the period of 2014 to ... in the market, and owns a wide product portfolio including ... Neurostimulator are some of the most popular brands of the ...
Breaking Medicine Technology:Surna, Inc. Announces Senior Leadership Changes 2Surna, Inc. Announces Senior Leadership Changes 3Surna, Inc. Announces Senior Leadership Changes 4UE Systems Renowned "Ultrasound World" Conference Celebrates its 11th Year 2Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 2Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 3Middle East & Africa Internal Neurostimulation/Neuromodulation Market is Expected to Reach $6.1 Million by 2019, at a CAGR of 17.9% from 2014 to 2019 4
... 6, 2011 Actavis, an international generic pharmaceuticals ... approval from the US Food & Drug Administration ... mg CIV.  Distribution of the product has commenced. ... to launch Zolpidem Tartrate Extended-Release Tablets 6.25 mg strength ...
... June 6, 2011 Brainlab announced today ... acquire Voyant Health. Voyant Health,s core technology, ... and to plan and digitally template surgical procedures from ... the operating room (OR). Another key technology is VoyantLink™, ...
Cached Medicine Technology:Actavis Receives FDA Approval of Zolpidem Tartrate Extended-Release Tablets USP, 12.5 mg CIV in the U.S. 2Brainlab Acquires Voyant Health 2Brainlab Acquires Voyant Health 3
(Date:2/26/2015)... Danvers, MA (PRWEB) February 27, 2015 ... of enterprise mobility management services, and one of ... announced they have engaged business development firm The ... CLEAN 4.0, Wireless Analytics’ latest iteration of the ... suite of services. The Endurance Group, based ...
(Date:2/26/2015)... Falls Church, VA (PRWEB) February 27, 2015 ... Edition, **FDAnews Publication**, http://www.fdanews.com/GuideToFDAMDRegs2015 , Whether a ... predicate device in a simple 510(k) filing or implement ... one thing all regulatory professionals need. The most up-to-date, ... why the Guide to FDA Medical Device Regulations is ...
(Date:2/26/2015)... (PRWEB) February 27, 2015 New ... is pleased to announce it is accepting new ... in Chesapeake, Va. , The new location ... physical therapy and rehabilitation programs, including the following ... and post orthopedic care, -Vestibular rehabilitation, -Neurological rehabilitation, ...
(Date:2/26/2015)... Dallas, Texas (PRWEB) February 27, 2015 ... Sodium Benzoate Industry is a professional and in-depth ... Sodium Benzoate industry with a focus ... in Sodium Benzoate market research are Wuhan Youji, ... Sonef, CG Chemikalien, MOLLER CHEMIE and W.ULRICH. , ...
(Date:2/26/2015)... (PRWEB) February 26, 2015 In this ... professional runner Dr. Anne Shadle discusses her study that ... gold medal-winning athletes in Track and Field. Shadle wanted ... and technical training that impacted athletes’ success and helped ... she uncovered seem not only critical to peak athletic ...
Breaking Medicine News(10 mins):Health News:Wireless Analytics Engages The Endurance Group to Promote Upcoming CLEAN Platform™ 4.0 Launch 2Health News:Wireless Analytics Engages The Endurance Group to Promote Upcoming CLEAN Platform™ 4.0 Launch 3Health News:FDAnews Bestseller Updated: Guide to FDA Medical Device Regulations — 2015 Edition 2Health News:Tidewater Physical Therapy Accepting New Patients at Relocated Battlefield Clinic 2Health News:Global Sodium Benzoate Industry Analysis Report 2015-2020 Now at DeepResearchReports.com 2Health News:Global Sodium Benzoate Industry Analysis Report 2015-2020 Now at DeepResearchReports.com 3Health News:Anne Shadle and Controlling the Olympic Moment on SCI TV 2Health News:Anne Shadle and Controlling the Olympic Moment on SCI TV 3
... Organic chemistry textbooks will need to be revised to ... species - pentamethylcyclopentadienyl cation (a positively charged ion) - ... said it was unstable. // ,"I’ve said this ... in organic chemistry class, but, as it turns out, ...
... ingenuous technique which reshape the throat area helps people who ... operation, involving the co-ordinated action of various of the cranial ... at the upper end of the digestive tract// - that ... nerve is paralysed, aspiration of food down to the lungs, ...
... when a couple has sex and any subsequent risk of ... that the timing of sex might increase the risk of ... professor of obstetrics and gynecology at Baylor College of Medicine ... one of the known causes of birth defects in lower ...
... Queensland group have developed an efficient method of identifying ... of diseases such as meningococcal disease. The ... of Technology (QUT) has taken advantage of two new ... sequencing recently - DNA chip technology and comparative gene ...
... filtering out the antibodies that can cause donor kidney rejection ... patients need a kidney transplant but are denied one because ... bodies, are in short supply, and to have a kidney ... compatible blood group. ,But doctors at Johns Hopkins ...
... anti-ageing research, the liver is a neglected key. Professor ... felt that there are many wonderful things about getting ... mortgage is paid off, your children have moved out, ... have the benefit of wisdom and resilience," he said. ...
Cached Medicine News:Health News:Identifying bacteria made amiable 2Health News:Liver key to extending life 2
... ARUP Laboratories is a national reference ... development organization. ARUP offers an extensive ... unique medical tests in clinical and ... of Utah, ARUP Laboratories clients include ...
Disposable Microscissors: Horizontal Curved Microscissors...
Sharp tipped straight scissors. For cutting in the iris plane or cutting peripheral membranes. May also be useful in ROP cases....
Tapered Shaft Microscissors : Williams Curved SharpTipped Scissors...
Medicine Products: